Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston Tan

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
JCO Precision Oncology|July 12, 2021
Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate CancerEdmond M Kwan, Chao Dai, Heidi Fettke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder CancerChristophe Massard, Michael S Gordon, Sunil Sharma, et al.
Ebiomedicine|December 27, 2019
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patientsBenoit You, Frédéric Mercier, Eric Assenat, et al.
Molecular Cancer Therapeutics|March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate CancerAdam M Kase, Justyna Gleba, James L Miller, et al.
BMC Medicine|March 25, 2022
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancerBlossom Mak, Hui-Ming Lin, Edmond M Kwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
JCO Precision Oncology|July 12, 2021
Plasma Cell-Free DNA Profiling of PTEN-PI3K-AKT Pathway Aberrations in Metastatic Castration-Resistant Prostate CancerEdmond M Kwan, Chao Dai, Heidi Fettke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder CancerChristophe Massard, Michael S Gordon, Sunil Sharma, et al.
Ebiomedicine|December 27, 2019
The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patientsBenoit You, Frédéric Mercier, Eric Assenat, et al.
Molecular Cancer Therapeutics|March 5, 2024
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate CancerAdam M Kase, Justyna Gleba, James L Miller, et al.
BMC Medicine|March 25, 2022
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancerBlossom Mak, Hui-Ming Lin, Edmond M Kwan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2017
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone ResistanceManish Kohli, Yeung Ho, David W Hillman, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
Pageof 9